• GeneDx Holdings held its annual shareholder meeting on June 18, 2026.
• Shareholders backed the selection of a Class II director for a three-year term; the vote authorized the appointment but did not itself implement board service.
• Ernst & Young was ratified as independent auditor for the fiscal year ending Dec. 31, 2026; the vote endorsed the appointment rather than constituting the audit.
• Shareholders supported holding future advisory votes on executive pay every year; the result signaled preference but did not set a binding schedule.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-044806), on June 23, 2026, and is solely responsible for the information contained therein.